Ishii et al. stated that CuD increases apoptosis-related Caspase-3, Caspase-9, and PARP levels, reduces antiapoptotic Bcl-2 levels, and decreases mitochondrial membrane potential in endometrial and ovarian cancer cells (Ishii et al., 2013). The gene discussed is BCL2; the disease is ovarian carcinoma.